In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT için istatistikler
Toplam ziyaret
views | |
---|---|
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT | 2 |
Aylık toplam ziyaret
views | |
---|---|
Ekim 2024 | 0 |
Kasım 2024 | 0 |
Aralık 2024 | 2 |
Ocak 2025 | 0 |
Şubat 2025 | 0 |
Mart 2025 | 0 |
Nisan 2025 | 0 |